Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
The Food and Drug Administration’s approval of low-risk tobacco pouches is welcome, but why did it delay for more than four ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...
The new indications, approved Tuesday by the FDA, make Ozempic the most broadly indicated drug in its class ... clinicians with their decision-making process, and it helps them focus those ...
That gave the FDA a way to communicate expectations to drugmakers about how clinical trials should be conducted to support a drug approval ... There is a formal process for removing guidance ...